Rethinking rare disease diagnosis in Canada
Open Access Government · 16.04.2026 · 50 (1) · 90-91
DOI: 10.56367/oag-050-12531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Access Government, erschienen am 16.04.2026. Verfasst von Francois P Bernier und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Rethinking rare disease diagnosis in Canada Authors from the Canadian Rare Disease Network (CRDN) explain how a genomics-informed learning health system would facilitate better data sharing and improve diagnostic processes, ultimately benefiting patients with rare diseases. Rare diseases (RDs) collectively affect more than 3 million people in Canada, yet timely diagnosis remains one of the most persistent challenges in the health system. For individuals and families, a diagnosis is not simply a label – it is a gateway to appropriate care, access to therapies and clinical trials, participation in research, and connection to essential supports.
Zitieren
APA
Bernier, F. P., Boycott, K. M., Ward, L. M., Stedman, I., Wong-Rieger, D., & Espenhahn, S. (2026). Rethinking rare disease diagnosis in Canada. Open Access Government, 50(1), 90-91. https://doi.org/10.56367/oag-050-12531
Vancouver
Bernier FP, Boycott KM, Ward LM, Stedman I, Wong-Rieger D, Espenhahn S. Rethinking rare disease diagnosis in Canada. Open Access Government. 2026;50(1):90-91. doi:10.56367/oag-050-12531
BibTeX
@article{Bernier2026,
author = {Bernier, Francois P and Boycott, Kym M and Ward, Leanne M and Stedman, Ian and Wong-Rieger, Durhane and Espenhahn, Svenja},
title = {Rethinking rare disease diagnosis in Canada},
journal = {Open Access Government},
year = {2026},
volume = {50},
number = {1},
pages = {90--91},
doi = {10.56367/oag-050-12531}
}
EUVIMED